Jun 1, 2026 11:11AM
May 19, 2026 03:14PM
May 3, 2026 08:00PM
Apr 17, 2026 02:00PM
Apr 17, 2026 02:00PM
Apr 15, 2026 07:00AM
Apr 13, 2026 07:00AM UCB announces new clinical data from its generalized myasthenia gravis (gMG) portfolio at the 2026 American Academy of Neurology (AAN) meeting
Mar 27, 2026 09:00AM
Mar 27, 2026 09:00AM
Mar 24, 2026 02:46PM
Mar 11, 2026 07:00AM
Dec 8, 2025 07:00AM
Dec 8, 2025 07:00AM
Dec 4, 2025 08:12AM UCB shares leading scientific research and advances at American Epilepsy Society Annual Meeting
Nov 3, 2025 04:00PM
Nov 3, 2025 04:00PM
Nov 3, 2025 04:00PM
Oct 29, 2025 12:00PM
Oct 29, 2025 07:00AM
Oct 25, 2025 11:00AM
Oct 13, 2025 07:00AM Results published in Neurology highlight a 95% reduction in risk of death with pyrimidine nucleos(t)ide therapy in patients with thymidine kinase 2 deficiency (TK2d)
Sep 17, 2025 07:00AM
Sep 17, 2025 07:00AM
Sep 10, 2025 08:00AM
Aug 29, 2025 01:15AM
Aug 5, 2025 08:00AM
Jul 8, 2025 07:00AM
Jun 27, 2025 07:00AM UCB announces positive results from GEMZ Phase 3 study of fenfluramine in CDKL5 deficiency disorder
Jun 20, 2025 07:00AM
Jun 17, 2025 08:22AM
Jun 12, 2025 12:30PM
Jun 12, 2025 01:00AM
Jun 11, 2025 12:16PM
May 19, 2025 12:30PM
Apr 3, 2025 07:00AM UCB presents latest research across leading neurology portfolio at American Academy of Neurology (AAN) meeting 2025
Mar 19, 2025 07:00AM
Mar 12, 2025 01:54PM
Mar 7, 2025 08:00AM
Mar 7, 2025 08:00AM
Feb 27, 2025 07:00AM
Jan 16, 2025 07:00AM
Dec 6, 2024 12:00PM UCB Presents New Data on Impact and Burden of Epilepsy at 2024 American Epilepsy Society (AES) Annual Meeting
Nov 26, 2024 07:00AM
Nov 20, 2024 07:00AM
Nov 19, 2024 01:00AM
Nov 14, 2024 12:46PM
Oct 11, 2024 07:00AM
Sep 30, 2024 07:00AM
Sep 27, 2024 07:00AM UCB Announces Late-Breaking Two-Year Data for BIMZELX® (bimekizumab-bkzx) in Moderate-to-Severe Hidradenitis Suppurativa at EADV 2024
Sep 25, 2024 07:00AM

1,157,576 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All